Keryx Receives European Approval for Fexericx for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease
September 24, 2015 at 07:02 AM EDT
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that the European Commission has approved Fexeric® (ferric citrate ...